OVID
OVID
NASDAQ · Biotechnology

Ovid Therapeutics Inc

$2.40
-0.14 (-5.51%)
Day Range $2.37 — $2.66
52W Range $1.18 — $3.11

Performance

1D +0.00%
1W -14.29%
1M +10.60%
3M -18.09%
6M -1.64%
1Y +84.62%
YTD +36.36%
Open$2.52
Previous Close$2.54
Day High$2.66
Day Low$2.37
52W High$3.11
52W Low$1.18
Volume—
Avg Volume2.97M
Market Cap461.45M
P/E Ratio—
EPS$-0.25
SectorBiotechnology

Technical Indicators

Full analysis →
SMA 50 $2.50 Below
SMA 200 $2.42 Below
RSI (14) 54.1 Neutral
Trend Golden Cross Bullish

Analyst Ratings

Strong Buy
19 analysts
18 Buy 1 Hold 0 Sell
Price Target +1,610.0% upside
Current
$2.40
Target
$41.04
$30.97 $41.04 avg $66.83

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 17.81M 10.53M 31.11M
Net Income -42,742,890 -22,750,370 -8,350,078
Profit Margin -240.1% -228.1% -26.8%
EBITDA -103,491,360 -58,144,651 -13,566,183
Free Cash Flow — — -8,976,737
Rev Growth +69.1% +69.1% +19.5%
Debt/Equity — — 0.28

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $294.55 -0.16% 50.3 520.47B
AMGN Amgen Inc $456.60 -1.24% 26.9 252.64B
GILD Gilead Sciences Inc $169.42 +1.10% — 208.95B
VRTX Vertex Pharmaceuticals Inc $531.97 -1.08% 33.9 134.82B
REGN Regeneron Pharmaceuticals $951.08 -0.14% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $159.73 -3.22% 7.7 20.98B